-
Treating Cancer Based on Its Genetics, Not Its Location
Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
by Anna Azvolinsky
-
An Uncommon Partnership
Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
The Genetics of Metastatic Cancer
The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
-
Paying for Tumor Testing
A recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.
by Brad Jones
-
The Ins and Outs of Tumor Testing
In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
-
A New Type of Drug Approval
At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.
by Kate Yandell
-
A Better Way to Screen for Lynch Syndrome?
Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.
by Cheryl Platzman Weinstock
Previous |
Cancer Talk
An Evidence-Based Guide to Integrative Medicine
ASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.
by Teresa Bergen
Comparing Costs of At-Home Colorectal Screening TestsCologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
A Personal Journey of Thyroid Cancer TreatmentThe practical side of cancer treatment and life without a thyroid.
by Carly Flumer
Women Less Satisfied With Cancer CareCompared with men, women’s initial cancer symptoms are less likely to be taken seriously.
by Sandra Gordon